The VB100 Launch Day: China's First Healthcare Industry Announcement Event Backed by an Impact Factor Formula
In 2018, the healthcare industry underwent a turbulent evolution, characterized by cross-sectoral interactions, innovation, and growth across various domains, ultimately leading to clearer development pathways. However, uneven information distribution within the industry has, to some extent, hindered its progress.
VCBeat, as an observer and recorder of the industry,It is hoped that a platform can be established to centralize the dissemination of extensive information,Accelerate information equilibrium within the industry, fostering new technological innovations and breakthroughs; and leverage the resulting agglomeration effect to deepen outsiders’ understanding of the healthcare sector.Under such a concept,VB100 Release DateIt was born, marking China’s first Healthcare Industry Release Day.
One Impact Factor Formula Deduces the Logic Behind the VB100 Release Date.
*The promotional content for this VB100 launch day features major announcements from seven institutions/companies, including publicly listed firms, unicorns, and innovative startups. Distribution channels include over 50 mainstream media outlets covering healthcare, finance, technology, and government sectors, as well as self-media platforms that organically amplify the content as it gains traction, with an estimated exposure of over 1 million impressions. A key impact factor is the concurrent grand opening of the 2018 Future Healthcare 100, which identifies the core forces driving transformation and development in the future healthcare industry.
This VB100 release date has attractedAlibaba Cloud, Deshang Yunxing, Tisu Technology, NVIDIA, Yixu Medical, Health Beneficial, DHIC7 Enterprises/Institutions ConductedNew Products, Financing, Reports, Strategy, PartnershipsNew Launches in Five Directions.
(List continues to grow)
Alibaba Cloud Digital Imaging Service: Brand New Launch
As a global leader in cloud computing and artificial intelligence technology, Alibaba Cloud provides secure and reliable computing and data processing capabilities. With the advancement of technology and hospital operations, as well as the growing need to serve patients, medical digital imaging faces challenges such as escalating storage demands, difficulties in sharing, data security concerns, and patient accessibility issues. In collaboration with numerous partners, Alibaba Cloud has jointly launched an Imaging Cloud solution. Covering image storage, sharing, and intelligent applications, this solution supports mobile image review for physicians and self-service query access for patients. It enables cross-institutional sharing of imaging resources, helps avoid redundant scans, assists physicians in image interpretation, and builds a boundary-less smart healthcare digital imaging service.
Desun Yunxing Launches New AI-Assisted Diagnostic Product for Breast Cancer
Deshang Yunxing is the first company in China to enter the AI-plus-ultrasound sector, and its independently developed “Intelligent Auxiliary Diagnosis System for Thyroid Nodules via Ultrasound” ranks among the world’s leading solutions. The Series B financing completed in June has been allocated to the continued R&D and commercial deployment of the AI-Sonic product series.
It is reported that Deshang Yunxing will launch a new AI-assisted diagnostic product for breast cancer. In terms of functionality, the product performs qualitative and quantitative analysis of lesions in accordance with the Chinese Guidelines for Breast Cancer, and classifies lesions using the BI-RADS system based on ACR standards. The product will be available in different versions tailored for tertiary hospitals and primary care facilities, thereby genuinely supporting the tiered diagnosis and treatment system.
Voxel Technology specializes in AI research and development for medical applications. Its product portfolio spans lung cancer diagnosis, fundus disease screening, and coronary CT angiography analysis systems, which have been deployed in clinical settings at more than 50 renowned hospitals both in China and abroad. The company has attracted investment from Sequoia Capital and Tencent, securing three rounds of funding totaling hundreds of millions of RMB within two years.
It is reported that on the VB100 release day, Voxel Technology will announce a new round of financing, and a brand-new product, “Voxel Skin Insight Hub,” is set to launch.This is a deep learning analytics system that is image-based yet goes beyond images.
International Data Corporation (IDC) is a globally renowned professional provider of consulting, advisory, and event services for the information technology, telecommunications, and consumer technology sectors. With more than 1,100 analysts worldwide, IDC delivers global, regional, and local expertise and insights on technological and industrial development opportunities in over 110 countries.
As the foundational technological backbone of artificial intelligence, NVIDIA’s GPU hardware and related software products are accelerating the rapid development of AI technologies, playing a pivotal role in advancing the field of AI-assisted radiology. The company has already partnered with 75 organizations in the healthcare sector—including medical centers, healthcare startups, research institutions, and medical imaging companies—providing them with AI technology support.
It is reported that on the VB100 launch day, NVIDIA and IDC China will jointly release a major report on their collaborative specialized medical artificial intelligence platform, comprehensively detailing the journey of driving medical AI from experimentation to practical application. The report covers the current state and future trends of medical AI development, the development of AI systems in the healthcare industry, and how the NVIDIA Clara supercomputing platform enhances diagnostic and therapeutic capabilities.
Yixu Medical holds patents for its target region gene capture technology with fully independent intellectual property rights. By leveraging pharmacogenomics to guide personalized precision medication and integrating clinical pharmacy services, the company enters chronic disease management through precision prescribing. After three years of focused development, it has established project collaborations with more than 130 renowned hospitals across 21 provinces and four major municipalities directly under the central government, boasting the most extensive geographic distribution of chronic disease patient samples and a comprehensive chronic disease medication database.
It is reported that Yixu Medical will unveil its new strategy for chronic disease management on the VB100 launch day. The strategy comprises four major systems: a precision medication service system for chronic diseases, a technological platform system for chronic disease management, a professional talent system for precision medication, and a research collaboration system for precision medicine. Key initiatives include developing regional medical consortia, and creating electronic medication history systems and AI-powered intelligent prescription decision-support systems.
Based on its self-developed ego-Healthcare Smart Brain, Healthyou has built its core product, the Healthcare AI Technology Open Platform (Health AI), which is China’s first AI technology open platform in a vertical sector.
It is reported that on the VB100 launch day, Health Youyi will comprehensively introduce the capabilities and research achievements of its Health AI platform, covering health assessment, AI-powered meal planning, posture correction, volume estimation, health records, medical consultation, and intelligent triage. This initiative aims to fully empower seven major scenarios: smart homes, smart communities, smart elderly care, smart healthcare, smart mobility, new retail, and government/enterprise applications.
Digital Health Innovation Center (DHIC), established byTencent, Tasly, China Electronics Data, VCBeatJointly developed. Committed to building a high-end resource matchmaking platform for the greater health industry, centered on user needs, dedicated to serving users, and focused on connecting the industry. By developing two core products, four key capabilities, five major traffic entry points, and five connection methods, we aim to establish a fully integrated, parallel closed-loop system for user data and services, fostering an open, shared, innovative, and inclusive digital innovation ecosystem in the greater health sector.
3 new product launches, 1 financing announcement, 1 report release, 1 strategy launch, 1 partnership announcement, we look forward to bringing new sparks and insights to the innovation and transformation of the healthcare industry.
December 18, 2018, Renaissance Beijing Capital Hotel: China’s First Healthcare Industry Launch Day is coming to you!
At the same time and venue, VCBeat’s annual flagship event, the 2018 Future Healthcare Top 100 Forum, will also kick off in grand style. We cordially invite you to join 152 industry luminaries in exploring the underlying patterns driving the future development of healthcare.
(Scan the QR code now to register and enjoy an instant discount of 100 yuan)